NASDAQ:DYN | Profit Breakdown | Dyne Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$181.66M-$178.56M
2026-03-31-$125.28M-$120.85M
2025-12-31-$116.13M-$111.96M
2025-09-30-$113.89M-$108.04M
2025-06-30-$115.79M-$110.86M
2025-03-31-$122.37M-$115.36M
2024-12-31-$97.11M-$89.54M
2024-09-30-$105.57M-$97.13M
2024-06-30-$71.96M-$65.1M
2024-03-31-$69.16M-$65.65M
2023-12-31-$67.69M-$66.64M
2023-09-30-$62.27M-$60.21M
2023-06-30-$66.74M-$64.9M
2023-03-31-$45.46M-$44.19M
2022-12-31-$40.15M-$38.83M
2022-09-30-$42.28M-$41.39M
2022-06-30-$52.76M-$52.3M
2022-03-31-$35.78M-$35.58M
2021-12-31-$51.96M-$51.79M
2021-09-30-$42.77M-$42.58M
2021-06-30-$30.17M-$29.96M
2021-03-31-$25.13M-$24.97M
2020-12-31-$28.6M-$28.65M
2020-09-30-$13.52M-$13.92M
2020-06-30-$8.68M-$8.98M
2020-03-31-$7.85M-$7.89M
2019-12-31-$5.47M-$5.4M
2019-09-30-$3.63M-$5.87M
2019-06-30-$1.5M
2019-03-31-$2.09M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$468.18M-$446.21M
2024-12-31-$343.89M-$317.42M
2023-12-31-$242.16M-$235.94M
2022-12-31-$170.96M-$168.1M
2021-12-31-$150.03M-$149.29M
2020-12-31-$58.65M-$59.44M
2019-12-31-$13.83M-$14.86M